Shanghai Pharmaceuticals Holding Co. Ltd. announced that Ms. CHEN Jinzhu (Ms. CHEN) has resigned as the secretary of the Board (the Board Secretary), the joint company secretary (the Joint Company Secretary), the authorized representative (the Authorised Representative) of the Company under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the Listing Rules), and the authorized representative for the acceptance of service of process and notices in Hong Kong on behalf of the Company under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) (the Authorized Representative under Companies Ordinance) due to internal work re-allocation of the Company, with effect from 29 August 2022. Ms. CHEN has confirmed that there is no disagreement between CHEN and the Board and there are no matters that need to be brought to the attention of the shareholders of the Company in relation to her above resignation.

The Board announced that Mr. ZHONG Tao (Mr. ZHONG) has been appointed as the Board Secretary, the Joint Company Secretary, the Authorised Representative and the Authorized Representative under Companies Ordinance, with effect from 29 August 2022. Another Joint Company Secretary of the Company, Ms. LEUNG Shui Bing (Ms. LEUNG) will assist Mr. ZHONG in discharging his duties as the Joint Company Secretary. Biographical details of Mr. ZHONG are set out below: Mr. ZHONG, born in June 1972, graduated from Fudan University with a postgraduate degree in business management and have obtained a master's degree.

ZHONG is currently the vice president of the Company. He was a member of the party committee, an executive director and a vice president of Shanghai Industry City Development Group Co. Ltd., and a party committee member, a director and a vice president of Shanghai Chengkai (Group) Co.

Ltd., a director of Tianjin Trust Co. Ltd., a director of Shangshi Management (Shanghai) Co. Ltd., the person in charge of the preparation for the party organization of Jinhushen Biopharmaceutical Technology Co.

Ltd., a director of planning of Shangshi Management (Shanghai) Co. Ltd., an assistant to the general manager of Shanghai Galaxy Investment Co. Ltd., and a project manager of the investment department of Shangshi Real Estate (Shanghai) Co.

Ltd., etc.